Literature DB >> 1123377

Malignant hemangioendothelioma of bone.

S E Larsson, R Lorentzon, L Boquist.   

Abstract

The clinical and histopathological characteristics are described in seven cases of malignant hemangioendothelioma of bone. This rare neoplasm affects all age groups and almost any bone. Metastases appear in the skeleton even before such lesions are seen on pulmonary roentgenograms. Prognosis is poor, with a five-year survival for only two of the six patients in this series. One patient is still alive and free of symptoms more than twelve years after diagnosis of widespread tumor destruction of the frontal skull bones, which was successfully controlled by radiation therapy. In addition, a recently diagnosed case of this tumor arising in a chronic non-fistulous osteomyelitic bone is described.

Entities:  

Mesh:

Year:  1975        PMID: 1123377

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  5 in total

1.  Case report 458: Low grade hemangioendothelioma of the clavicle and acromion.

Authors:  D J Lye; J F Wepfer; D S Haskell
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

2.  Surgical management of haemangioendothelioma of the spine.

Authors:  D S Marks; A M Thomas; A G Thompson; S Mills
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

3.  Unilateral proptosis as a clinical presentation in primary angiosarcoma of skull.

Authors:  S Shuangshoti; P Chayapum; N Suwanwela; C Suwanwela
Journal:  Br J Ophthalmol       Date:  1988-09       Impact factor: 4.638

4.  Primary calvarial angiosarcoma: A case report and review of the literature.

Authors:  Imad S Khan; Jai D Thakur; Osama Ahmed; Cedric D Shorter; Jaiyeola Thomas-Ogunniyl; Mary T Kim; Majed A Jeroudi; Bharat Guthikonda
Journal:  Surg Neurol Int       Date:  2012-10-29

5.  Multi-focal, multi-centric angiosarcoma of bone.

Authors:  E Kakouri; J S Whelan; S Coltart; M E Smith; R L Souhami
Journal:  Sarcoma       Date:  1997
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.